Skip to main content

Table 6 Tissue Phase Mapping in CKD

From: A comprehensive characterization of myocardial and vascular phenotype in pediatric chronic kidney disease using cardiovascular magnetic resonance imaging

 

Healthy Controls

(n = 20)

Mild CKD

(n = 40)

Moderate CKD

(n = 40)

Severe CKD

(n = 20)

P-value

Rad S′ (cm/s)

2.7 ± 0.31

2.6 ± 0.24

2.5 ± 0.38

2.4 ± 0.31

0.003

Rad E’ (cm/s)

4.2 ± 0.59

3.6 ± 0.62

3.4 ± 0.78

3.3 ± 0.53

< 0.001

Rad A’ (cm/s)

1.3 ± 0.35

1.1 ± 0.34

1.2 ± 0.31

1.2 ± 0.28

0.30

Long S′ (cm/s)

4.6 ± 1.6

3.9 ± 1.1

3.4 ± 1.3

3.6 ± 1.3

0.009

Long E’ (cm/s)

7.9 ± 1.5

7.5 ± 2.0

6.7 ± 1.8

6.8 ± 1.4

0.046

Long A’ (cm/s)

2.3 ± 0.71

2.5 ± 1.1

2.7 ± 0.85

2.5 ± 0.64

0.61

Long E’/A’ ratioa

3.4 ± 1.3

3.2 ± 1.6

2.6 ± 1.4

2.8 ± 1.3

0.003†

Long E/E’ ratioa

6 ± 1.2

6.7 ± 1.3

7.5 ± 1.4

7.3 ± 1.4

0.03

  1. Bonferroni correction applied- p < 0.006 is considered significant
  2. Abbreviations: CKD chronic kidney disease, Rad radial, Long longitudinal, S′ systolic myocardial velocity, E’ early diastolic myocardial velocity, A’ late diastolic myocardial velocity, E’/A’ E’ over A’ ratio, E/E’ E over E’ ratio
  3. aLogarithmic transformation was applied
  4. †ANOVA Welch (W) test was used